WeDaita
Research Digest
AI-curated papers, approvals, clinical compounds, and disclosures from drug discovery's leading sources.
Scored for relevance by WeDaita AI · Updated weekly · Not editorial contentComputational and medicinal chemistry advances, approved drugs, and clinical pipeline entries across the full drug design lifecycle.
- Literature — AI-driven molecular generation, virtual screening, ADMET prediction, and structure-based design from PubMed, arXiv, and Semantic Scholar
- FDA Approval — Recently approved small-molecule drugs (NDA approvals) sourced from openFDA
- Clinical Compound — Phase I–III candidates from ChEMBL — molecules in active clinical development not yet approved
- Disclosure — New molecular series and compound profiles curated by Drug Hunter
- Patent — Drug Hunter Patent Gazette roundups with expert annotations on assignees, targets, and key novelty claims
- Industry News — Company announcements, funding rounds, and biotech media coverage
Literature
Scal3R: Learning Efficient Multi-Relative Pose Query for Scalable Online 3D Reconstruction
Literature
Compile by Training: Turning Natural-Language Specifications into Local Neural Functions
Literature
TokenMatch: 3D Mesh Correspondence Transformer with Curvature-Guided Tokenisation
Full access requires a free account
Sign in to browse 3 curated items — papers, FDA approvals, clinical compounds, and disclosures.
Sign in for full access